• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直接经皮冠状动脉介入治疗前 TIMI 3 级通畅对 ST 段抬高型心肌梗死临床结局的影响:ASSENT-4 PCI 研究结果。

Impact of TIMI 3 patency before primary percutaneous coronary intervention for ST-elevation myocardial infarction on clinical outcome: results from the ASSENT-4 PCI study.

机构信息

Herzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany.

出版信息

Eur Heart J Acute Cardiovasc Care. 2012 Jun;1(2):136-42. doi: 10.1177/2048872612447069.

DOI:10.1177/2048872612447069
PMID:24062901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3760529/
Abstract

BACKGROUND

Early restoration of blood flow of the infarct-related artery is associated with an improved outcome in patients with ST-elevation myocardial infarction (STEMI). Previous studies have shown a low mortality in patients with TIMI 3 flow before primary percutaneous coronary intervention (PCI). Most likely these patients had spontaneous recanalization of the infarct vessel and might constitute a low-risk subgroup. The purpose of the present analysis was to investigate whether TIMI 3 flow obtained with fibrinolysis before PCI is associated with a clinical outcome comparable to that in patients with spontaneous TIMI 3 flow.

METHODS

Patients with STEMI <6 hours enrolled in the ASSENT-4 PCI study were randomized to facilitated PCI with tenecteplase or primary PCI. For this analysis, patients were divided into three groups according to the TIMI flow of the infarct vessel before PCI: TIMI 0/1, TIMI 2, and TIMI 3.

RESULTS

From a total of 1617 patients, 861 had TIMI 0/1, 279 had TIMI 2, and 477 TIMI 3 flow. The rates of TIMI 3 flow after PCI were 84.6, 89.7, and 95.6%, respectively. Complete ST resolution was observed most often in the TIMI 3 flow group (47.5, 53.6, and 58.6%). The incidence of cardiogenic shock (6.2, 5.5, and 3.6%) and 90-day mortality (6.1, 4.7, and 4.0%) were lowest in the group with TIMI 3 patency before PCI, respectively. The rate of TIMI 3 flow before PCI was higher in the facilitated PCI group than in the primary PCI group (43.9 vs. 15.2%). The 90-day mortality in patients with TIMI 3 before PCI was identical in the facilitated and the primary PCI groups (14/353, 4.0% vs. 5/124, 4.0%).

CONCLUSION

In this post-hoc analysis of ASSENT-4 PCI, TIMI grade 3 flow in the infarct-related artery before PCI, occurring either spontaneously or obtained by fibrinolysis, is associated with a higher TIMI patency after PCI, better improved ST resolution and a trend towards a favourable clinical outcome after 90 days.

摘要

背景

ST 段抬高型心肌梗死(STEMI)患者梗死相关动脉的早期血流恢复与改善预后相关。先前的研究表明,在直接经皮冠状动脉介入治疗(PCI)前,出现 TIMI 3 级血流的患者死亡率较低。这些患者很可能自发地使梗死血管再通,可能构成低危亚组。本分析的目的是探讨 PCI 前溶栓获得的 TIMI 3 级血流是否与自发获得 TIMI 3 级血流的患者的临床预后相当。

方法

ASSENT-4 PCI 研究中纳入的发病 6 小时内的 STEMI 患者被随机分配至接受替奈普酶辅助 PCI 或直接 PCI。对于这项分析,根据 PCI 前梗死相关血管的 TIMI 血流,患者被分为三组:TIMI 0/1 级、TIMI 2 级和 TIMI 3 级。

结果

在总共 1617 例患者中,861 例患者的 TIMI 0/1 级、279 例患者的 TIMI 2 级和 477 例患者的 TIMI 3 级。PCI 后 TIMI 3 级血流的发生率分别为 84.6%、89.7%和 95.6%。TIMI 3 级血流组最常观察到完全 ST 段缓解(47.5%、53.6%和 58.6%)。心原性休克的发生率(6.2%、5.5%和 3.6%)和 90 天死亡率(6.1%、4.7%和 4.0%)最低的是 PCI 前 TIMI 3 级血流开放组。辅助 PCI 组患者的 PCI 前 TIMI 3 级血流率高于直接 PCI 组(43.9%比 15.2%)。PCI 前 TIMI 3 级血流患者的 90 天死亡率在辅助 PCI 组和直接 PCI 组之间相同(353 例患者中的 14 例[4.0%]比 124 例患者中的 5 例[4.0%])。

结论

在 ASSENT-4 PCI 的这项事后分析中,梗死相关动脉 PCI 前自发或通过溶栓获得的 TIMI 3 级血流与 PCI 后更高的 TIMI 再通率、更好的 ST 段改善和 90 天后临床预后的改善趋势相关。

相似文献

1
Impact of TIMI 3 patency before primary percutaneous coronary intervention for ST-elevation myocardial infarction on clinical outcome: results from the ASSENT-4 PCI study.直接经皮冠状动脉介入治疗前 TIMI 3 级通畅对 ST 段抬高型心肌梗死临床结局的影响:ASSENT-4 PCI 研究结果。
Eur Heart J Acute Cardiovasc Care. 2012 Jun;1(2):136-42. doi: 10.1177/2048872612447069.
2
Intraluminal thrombus in facilitated versus primary percutaneous coronary intervention: an angiographic substudy of the ASSENT-4 PCI (Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention) trial.易化与直接经皮冠状动脉介入治疗中的腔内血栓:ASSENT-4 PCI 试验(经皮冠状动脉介入治疗新治疗策略的安全性和有效性评估)的血管造影子研究。
J Am Coll Cardiol. 2011 May 10;57(19):1867-73. doi: 10.1016/j.jacc.2010.10.061.
3
Frequency of Thrombolysis in Myocardial Infarction III Flow in Patients With Primary Percutaneous Coronary Intervention: Not All Culprit Vessels Are Completely Occluded in ST Elevation Myocardial Infarction.接受直接经皮冠状动脉介入治疗的心肌梗死溶栓治疗III级血流患者的发生率:并非所有罪犯血管在ST段抬高型心肌梗死中均完全闭塞。
Cureus. 2020 Dec 12;12(12):e12036. doi: 10.7759/cureus.12036.
4
Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.原代 B 型利钠肽前体 N 端片段浓度与治疗时间及心肌梗死溶栓治疗 (TIMI) 血流的关系:经皮冠状动脉介入治疗评估新治疗策略安全性和有效性的一项亚组研究 (ASSENT IV-PCI 试验)。
Am Heart J. 2010 Jan;159(1):131-40. doi: 10.1016/j.ahj.2009.11.001.
5
Use and impact of thrombectomy in primary percutaneous coronary intervention for acute myocardial infarction with persistent ST-segment elevation: results of the prospective ALKK PCI-registry.血栓切除术在持续性ST段抬高型急性心肌梗死直接经皮冠状动脉介入治疗中的应用及影响:前瞻性ALKK PCI注册研究结果
Clin Res Cardiol. 2015 Oct;104(10):803-11. doi: 10.1007/s00392-015-0846-z. Epub 2015 Mar 25.
6
Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction).症状发作后极早期行院前启动的辅助经皮冠状动脉介入治疗与直接经皮冠状动脉介入治疗治疗急性心肌梗死的随机比较:LIPSIA-STEMI 试验(莱比锡即刻院前辅助 ST 段抬高型心肌梗死血管成形术)
JACC Cardiovasc Interv. 2011 Jun;4(6):605-14. doi: 10.1016/j.jcin.2011.01.013.
7
Clinical significance of post-procedural TIMI flow in patients with cardiogenic shock undergoing primary percutaneous coronary intervention.经皮冠状动脉介入治疗术后 TIMI 血流对心原性休克患者的临床意义。
JACC Cardiovasc Interv. 2009 Jan;2(1):56-64. doi: 10.1016/j.jcin.2008.10.006.
8
Impact of acute infarct-related artery patency before percutaneous coronary intervention on 30-day outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention in the EUROMAX trial.在 EUROMAX 试验中,对于接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者,急性梗死相关动脉再通对 30 天结局的影响。
Eur Heart J Acute Cardiovasc Care. 2018 Sep;7(6):514-521. doi: 10.1177/2048872617690888. Epub 2017 Feb 20.
9
Effect of high-intensity statin preloading on TIMI flow in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.高强度他汀预负荷对接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者心肌灌注分级血流的影响。
Egypt Heart J. 2020 Jul 10;72(1):40. doi: 10.1186/s43044-020-00074-0.
10
[Effects of pretreatment with recombinant human B-type natriuretic peptide on infarct size in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].重组人B型利钠肽预处理对接受直接经皮冠状动脉介入治疗的急性ST段抬高型心肌梗死患者梗死面积的影响
Zhonghua Xin Xue Guan Bing Za Zhi. 2015 Nov;43(11):954-9.

引用本文的文献

1
Platelet-to-White Blood Cell Ratio (PWR): A Novel Prognostic Biomarker for Spontaneous Reperfusion after Primary Percutaneous Coronary Intervention.血小板与白细胞比值(PWR):原发性经皮冠状动脉介入治疗后自发再灌注的一种新型预后生物标志物。
J Saudi Heart Assoc. 2024 Nov 25;36(4):360-370. doi: 10.37616/2212-5043.1404. eCollection 2024.
2
Parenteral Anticoagulation at First Medical Contact Improves Infarct Related Artery Patency in STEMI.首次医疗接触时的肠外抗凝治疗可改善ST段抬高型心肌梗死患者梗死相关动脉的通畅情况。
J Clin Med. 2024 Mar 16;13(6):1710. doi: 10.3390/jcm13061710.
3
The Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort Study.接受替格瑞洛与氯吡格雷治疗的急性ST段抬高型心肌梗死患者在进行直接经皮冠状动脉介入治疗前初始TIMI血流分级的比较:一项前瞻性队列研究
Cardiol Res Pract. 2024 Feb 5;2024:6632656. doi: 10.1155/2024/6632656. eCollection 2024.
4
Clinical Characteristics and Outcome of Percutaneous Coronary Intervention in Yemeni Patients.也门患者经皮冠状动脉介入治疗的临床特征与结果
Heart Views. 2023 Apr-Jun;24(2):93-97. doi: 10.4103/heartviews.heartviews_98_22. Epub 2023 Mar 24.
5
The Role of ECG in the Diagnosis and Risk Stratification of Acute Coronary Syndromes: an Old but Indispensable Tool.心电图在急性冠脉综合征诊断和危险分层中的作用:一种古老但不可或缺的工具。
Curr Cardiol Rep. 2022 Feb;24(2):109-118. doi: 10.1007/s11886-021-01628-7. Epub 2022 Jan 13.
6
Association of coronary artery dominance and mortality rate and complications in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.ST段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗时冠状动脉优势与死亡率及并发症的相关性
J Res Med Sci. 2020 Nov 26;25:107. doi: 10.4103/jrms.JRMS_414_19. eCollection 2020.
7
Frequency of Thrombolysis in Myocardial Infarction III Flow in Patients With Primary Percutaneous Coronary Intervention: Not All Culprit Vessels Are Completely Occluded in ST Elevation Myocardial Infarction.接受直接经皮冠状动脉介入治疗的心肌梗死溶栓治疗III级血流患者的发生率:并非所有罪犯血管在ST段抬高型心肌梗死中均完全闭塞。
Cureus. 2020 Dec 12;12(12):e12036. doi: 10.7759/cureus.12036.
8
Association of culprit lesion plaque characteristics with flow restoration post-fibrinolysis in ST-segment elevation myocardial infarction: an intravascular ultrasound-virtual histology study.ST段抬高型心肌梗死患者罪犯病变斑块特征与纤溶后血流恢复的相关性:一项血管内超声-虚拟组织学研究
Egypt Heart J. 2020 Dec 9;72(1):86. doi: 10.1186/s43044-020-00121-w.
9
Oxidative stress and its association with ST resolution and clinical outcome measures in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention.氧化应激及其与接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死(STEMI)患者ST段恢复及临床结局指标的关联。
BMC Res Notes. 2020 Nov 11;13(1):525. doi: 10.1186/s13104-020-05350-5.
10
Admission homocysteine is an independent predictor of spontaneous reperfusion and early infarct-related artery patency before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction.入院时同型半胱氨酸是ST段抬高型心肌梗死患者在直接经皮冠状动脉介入治疗前自发再灌注和早期梗死相关动脉通畅的独立预测指标。
BMC Cardiovasc Disord. 2018 Jun 25;18(1):125. doi: 10.1186/s12872-018-0868-3.

本文引用的文献

1
Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial.院前给予高负荷剂量氯吡格雷对改善急性心肌梗死患者直接经皮冠状动脉介入治疗的疗效和安全性:随机 CIPAMI 试验。
Clin Res Cardiol. 2012 Apr;101(4):305-12. doi: 10.1007/s00392-011-0393-1. Epub 2011 Dec 21.
2
Causes of delay and associated mortality in patients transferred with ST-segment-elevation myocardial infarction.ST 段抬高型心肌梗死患者转院延迟的原因及相关死亡率。
Circulation. 2011 Oct 11;124(15):1636-44. doi: 10.1161/CIRCULATIONAHA.111.033118. Epub 2011 Sep 19.
3
Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay.更长的预处理时间与院前替罗非班联合应用可增强直接经皮冠状动脉介入治疗的疗效:保护延迟时间的负面影响。
EuroIntervention. 2011 Aug;7(4):442-8. doi: 10.4244/EIJV7I4A73.
4
Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals.易化经皮冠状动脉介入治疗在高危 ST 段抬高型心肌梗死患者转至非经皮冠状动脉介入治疗医院中的获益。
JACC Cardiovasc Interv. 2009 Oct;2(10):917-24. doi: 10.1016/j.jcin.2009.06.018.
5
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.持续性ST段抬高型急性心肌梗死患者的管理:欧洲心脏病学会ST段抬高型急性心肌梗死管理工作组
Eur Heart J. 2008 Dec;29(23):2909-45. doi: 10.1093/eurheartj/ehn416. Epub 2008 Nov 12.
6
Spontaneous reperfusion in ST-elevation myocardial infarction: comparison of angiographic and electrocardiographic assessments.ST段抬高型心肌梗死的自发再灌注:血管造影与心电图评估的比较
Am Heart J. 2008 Aug;156(2):248-55. doi: 10.1016/j.ahj.2008.03.018. Epub 2008 Jun 11.
7
Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis.早期糖蛋白IIb-IIIa抑制剂在直接经皮冠状动脉腔内血管成形术(EGYPT)协作组中的应用:一项个体患者数据荟萃分析。
Heart. 2008 Dec;94(12):1548-58. doi: 10.1136/hrt.2008.141648. Epub 2008 May 12.
8
Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial.替奈普酶辅助与直接经皮冠状动脉介入治疗ST段抬高型急性心肌梗死患者(ASSENT-4 PCI):随机试验
Lancet. 2006 Feb 18;367(9510):569-78. doi: 10.1016/S0140-6736(06)68147-6.
9
Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: a study performed with contrast-enhanced magnetic resonance.缺血持续时间是直接经皮冠状动脉腔内血管成形术后透壁性和严重微血管阻塞的主要决定因素:一项使用对比增强磁共振成像的研究
J Am Coll Cardiol. 2005 Oct 4;46(7):1229-35. doi: 10.1016/j.jacc.2005.06.054.
10
Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?急性心肌梗死直接经皮冠状动脉介入治疗的药物辅助:曲线斜率会成为未来的趋势吗?
JAMA. 2005 Feb 23;293(8):979-86. doi: 10.1001/jama.293.8.979.